CAR-T ARI-0001 shows high response rates in adult patients with acute lymphoblastic leukemia
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
On World Cancer Day, held every year on 4 February, Clínic Barcelona Comprehensive Cancer Centre (4CB) highlights its excellence in patient care an...
Elías Campo, head of the Molecular Pathology of Lymphoid Neoplasias research group at IDIBAPS ubicated at Esther Koplowitz Centre, has received a “...
On 14 January, the launch meeting of the European project CINNAMON (Connecting an INternational Network of Academic Manufacturers of ONcoimmunother...
Hospital Clínic Barcelona and the FERO Foundation have signed an agreement whereby the foundation joins the Clínic Barcelona Comprehensive Cancer C...
The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastuzum...
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Ann...
Hospitals that are part of the C17 alliance have launched the C17 Integrated Cancer Network (XIC-C17), an initiative aimed at strengthening coordin...
Today, 17 November, we mark World Lung Cancer Day — an occasion to raise awareness of this disease, acknowledge the efforts of patients and familie...
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...